Lombardi research: Robotic radiosurgery offers palliative care for hilar lung tumors
2010-11-03
(Press-News.org) Washington, DC – Patients report decreased pain and improved breathing following treatment of their hilar tumors with robotic radiosurgery, but researchers say the therapy falls short of improving survival. Still, the study, conducted by researchers at Georgetown Lombardi Comprehensive Cancer Center and presented today at the annual meeting of the American College of Chest Physicians in Vancouver, BC, represents the first of its kind to document the use of radiosurgery for hilar tumors and presents a novel therapy option.
For the study, researchers reviewed the medical records of patients diagnosed with inoperable primary and metastatic hilar lung tumors. Hilar tumors abut or invade the mainstem bronchus. All the patients in the study were treated with five courses (30 to 40 Gy in 5 fractions) of radiotherapy using CyberKnife. Imaging studies with a combined PET/CT scan were performed at three and six-month follow-up intervals to track tumor progression.
The record review included 24 patients -- four with inoperable primary hilar lung tumors and 20 with hilar tumors that had spread there from other primary sites. The mean radiation dose administered to the esophagus was 27 Gy (ranging from 11 to 40 Gy) and mean radiation dose administered to the lung was 45 Gy (ranging from 30 to 50 GY).
At one-year, the overall survival was 61 percent and local control (ability to keep the tumor from growing) was 71 percent.The review found that most deaths were attributed to the spread of the patients' cancers. However, there was one death that was attributed to an opening in the mainstem bronchus in a patient who was previously stented.
While no uniform data was collected from patients about quality of life at the time of their treatment, the study's lead author says the patient records reflect comments made by patients about their symptoms.
"Patients reported improvement with coughing, breathing, and they reported less pain," said Brian Collins, MD, a radiation oncologist with Lombardi and lead author of the study.
"Our study suggests that CyberKnife is a palliative treatment option for hilar lung tumors," explains Collins.
"We'd like to investigate outcomes with increased radiation doses to see if we can improve local control and overall survival rates. And we'd like to study the impact of administering a drug to make the tumors more sensitive to radiation.
"This is an important first step that gives us a new option to treat potentially morbid hilar tumor," Collins concludes. "Future studies would likely involve drugs to make the tumor more sensitive to radiation."
INFORMATION:
Collins is a compensated speaker for ACCURAY, the maker of the CyberKnife.
About Lombardi Comprehensive Cancer Center
The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university's sponsored research funding.
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-03
Fruit flies that grow obese after eating a diet loaded with fat could lead the way to the core elements of obesity, according to researchers who report their findings in the November issue of Cell Metabolism, a Cell Press publication.
The findings also get at obesity's origins. The demonstration that flies do become obese on a high-fat diet (HFD), much as humans do, indicates that the ability to become obese goes way, way back, the researchers say.
"The capacity for obesity is evolutionarily ancient," said Sean Oldham of the Sanford-Burnham Medical Research Institute. ...
2010-11-03
Researchers have identified a hormone produced and secreted by the liver as a previously unknown cause of insulin resistance. The findings, in the November issue of Cell Metabolism, a Cell Press publication, suggest a new target for the treatment of insulin resistance and type 2 diabetes, the researchers say.
"The current study sheds light on a previously underexplored function of the liver; the liver participates in the pathogenesis of insulin resistance through hormone secretion," said Hirofumi Misu of Kanazawa University Graduate School of Medical Science in Japan. ...
2010-11-03
In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir monotherapy. This key finding comes from a randomized, placebo-controlled trial— in adults presenting with influenza symptoms at general practices throughout France during the seasonal influenza epidemic in 2008-2009— carried out by Catherine Leport from the University of Paris, France, and colleagues, and reported in this week's PLoS Medicine.
In ...
2010-11-03
In this week's PLoS Medicine Magazine, Trisha Greenhalgh and Jill Russell from the Queen Mary University of London discuss the relative merits of "scientific" and "social practice" approaches to evaluation and argue that eHealth evaluation is in need of a paradigm shift. They critique the previous PLoS Medicine series on evaluating eHealth, published in late 2009.
INFORMATION:Funding: The ideas in this paper were developed during an independent evaluation of the UK Summary Care Record programme, funded by a research grant from the UK National Institute of Health Research ...
2010-11-03
David Henry discusses a recent research article in PLoS Medicine that suggests that relationships between doctors and drug companies are still too close. The research, by Geoffrey Spurling and colleagues, examined the relationship between exposure to promotional material from pharmaceutical companies and the quality, quantity, and cost of prescribing. David Henry's offers his Perspective in this week's PLoS Medicine Magazine.
INFORMATION:
Funding: The author received no specific funding for this article
Competing Interests: The author has declared that no competing ...
2010-11-03
BOSTON—The system for hospice admissions for patients with advanced dementia, which is a terminal illness, should be guided by patient and family preference for comfort, not estimated life expectancy, says a new study published in the Nov. 3 Journal of the American Medical Association by the Institute for Aging Research at Hebrew SeniorLife, an affiliate of Harvard Medical School.
Currently, patients requesting hospice services must be certified by their physician to have six months or less to live, and must sign a statement choosing comfort care services in lieu of curative ...
2010-11-03
In a study examining the factors that play a role in an older adult's transition to disability, intervening illnesses and injuries that led to hospitalization or activity restriction were associated with worsening functional ability, especially among those who were physically frail, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Thomas M. Gill, M.D., of the Yale University School of Medicine, New Haven, Conn., presented the findings of the study at a JAMA media briefing at the National Press Club.
Among older persons, disability in essential ...
2010-11-03
Use of a fall prevention tool kit, which included a fall risk assessment, patient-specific prevention plan, an educational handout and a poster for over the patient's hospital bed reduced the number of older patients with falls in hospitals, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Patricia C. Dykes, R.N., D.N.Sc., of Partners HealthCare System, Brigham and Women's Hospital and Harvard Medical School, Boston, presented the findings of the study at a JAMA media briefing at the National Press Club.
"Falls are a public health problem ...
2010-11-03
In a review of comprehensive primary care programs for older adults with multiple chronic conditions, authors identified three models that appear to have the greatest potential for improving quality of care and life for these patients, while reducing or not increasing the costs of their health care, according to an article in the November 3 issue of JAMA, a theme issue on aging.
Chad Boult, M.D., M.P.H., M.B.A., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, presented the findings of the study at a JAMA media briefing at the National Press Club.
"Older ...
2010-11-03
Patients with mild to moderate Alzheimer's disease (AD) who received supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA), believed to possibly reduce the risk of AD, did not experience a reduction in the rate of cognitive and functional decline, compared to patients who received placebo, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Joseph F. Quinn, M.D., of Oregon Health and Science University and the Portland VA Medical Center, Portland, Ore., presented the findings of the study at a JAMA media briefing at the National ...
LAST 30 PRESS RELEASES:
[Press-News.org] Lombardi research: Robotic radiosurgery offers palliative care for hilar lung tumors
